Stocks/BILI

BILI three-lens brief

Evidence-based stock research on BILI. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.

52-week rangeas of 08:00 ET
$15.16$15.47$36.40

Performance

1W
-0.2%
1M
-14.0%
3M
6M
YTD
1Y
3Y
5Y
BILI · Nightly brief
Concern

Moved -2.77% yesterday. · Trading at 1% of its 52-week range — deep in the lower band.

  • Moved -2.77% yesterday.
  • Trading at 1% of its 52-week range — deep in the lower band.
  • 50-day MA below 200-day MA (death-cross regime); price below both.
  • Underperforming SPY by 20.4pp over 30 days.
  • Analyst mean target $26.89 — 74% above current (29 analysts).

BILI closed at $15.47 (-2.77%) as of 2026-09-11. Market cap: $6.37B. P/E (trailing) 29.8. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $26.89 — 74% above current (29 analysts).. Concerns: moved -2.77% yesterday.; trading at 1% of its 52-week range — deep in the lower band.. Last quarter: Revenue $7.94B, net income $343.73M.

Market ✓· Fundamentals ✓
Informational only · Not investment advice
Three-lens method

Why three lenses on BILI, not one.

A single reasoning model has blind spots it doesn’t know about. We examine BILIacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.

Read the full methodology
Embed this brief

Drop it in your newsletter or blog.

Free to embed. Updates every 6 hours. Links back to the full brief.

<iframe
  src="https://clearpathinvest.app/embed/BILI"
  width="100%" height="420" frameborder="0"
  loading="lazy"
  title="ClearPath BILI brief"></iframe>